CTLs bind to melanoma cells via TAA presented on MHC molecules and then exert an antitumor effect on melanoma cells by releasing perforin and granzyme B to induce apoptosis and secreting cytokines such as IFN-γ and TNF to reinforce the inflammatory TME. This evidence concerns the gene PRF1 and melanoma.